SATTVA SCIENCE, LLC

SATTVA SCIENCE, LLC delivers specialized consulting services focused on medical device development and investment strategy, with deep expertise in the regulatory and commercialization pathways for health technologies. The firm provides subject matter expertise to guide innovation under initiatives like the Blueprint MedTech program, advising on technical design, clinical translation, and market readiness of medical devices. Their capabilities center on bridging scientific research with federal procurement and regulatory frameworks, ensuring alignment with FDA standards, reimbursement policies, and investor criteria. This niche focus enables them to support complex, high-stakes development cycles where technical rigor meets policy and market dynamics. The contractor has demonstrated direct engagement with the Department of Health and Human Services, delivering strategic advisory services tied to federal medical technology initiatives. Their work supports HHS’s mission to accelerate innovation in diagnostics, therapeutics, and device-based care delivery, particularly in areas requiring interdisciplinary collaboration between engineers, clinicians, and policy experts. SATTVA SCIENCE operates within the broader professional, scientific, and technical services sector, with primary emphasis on 541990—services that bridge scientific innovation and federal program execution. Their market positioning is defined by deep domain knowledge in medical device ecosystems, including pre-market development, clinical validation frameworks, and investment readiness assessments. They serve as a trusted advisor to agencies navigating the intersection of health technology innovation and public health outcomes. As a Women-Owned Small Business and Woman-Owned Business certified entity headquartered in Annapolis, Maryland, SATTVA SCIENCE, LLC brings a mission-driven perspective to federal contracting. Their small-business structure enables agile, high-touch engagement, while their certifications reflect a commitment to diversity and inclusion in the federal science and technology landscape. The firm’s geographic presence in the Mid-Atlantic region positions it well for collaboration with federal health agencies and biomedical research institutions.